Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06472089 · ClinicalTrials.gov registry record · NA
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
A NA study of Hematologic Malignancy and Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 3
- Study locations
NCT06472089 is a NA study of Hematologic Malignancy and Bone Marrow Transplant Complications that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 800 participants, above the 212-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (277% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT06472089, a NA study of Hematologic Malignancy and Bone Marrow Transplant Complications, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL BMT-CARE
Study Locations (3)
Alabama
- University of Alabama at Brimingham - Birmingham
Florida
- Moffitt Cancer Center - Tampa
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2029-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06472089
The ClinicalTrials.gov registry entry for NCT06472089 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 212-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (277% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hematologic Malignancy appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06472089 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06472089 about?
NCT06472089 is a clinical study titled "BMT-CARE: Psychosocial Intervention for Transplant Caregivers". The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementa...
What is the current status of trial NCT06472089?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2025-01-10. Estimated completion is 2029-02.
What conditions does trial NCT06472089 study?
This clinical trial studies the following conditions: Hematologic Malignancy, Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT06472089?
The interventions under investigation include: Usual Care (BEHAVIORAL), BMT-CARE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06472089?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06472089 being conducted?
This trial has 3 study locations across Alabama, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Malignancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
RECRUITING · NA
-
Implementation of an Oral Chemotherapy Adherence Intervention
RECRUITING · NA
-
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
RECRUITING · NA
-
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.